Target intelligence / Profile preview

Phenylalanine dehydrogenase (PheDH)

Target
PheDH
Molecular classification
Enzyme, Oxidoreductase, Dehydrogenase
01

Overview

Phenylalanine dehydrogenase (PheDH) is a microbial enzyme belonging to the oxidoreductase family that catalyzes the reversible oxidative deamination of L-phenylalanine into phenylpyruvate, utilizing NAD+ or NADP+ as a cofactor [1, 2]. Although not naturally occurring in humans, PheDH is widely produced by various bacterial species, including members of the genera Bacillus, Sporosarcina, and Rhodococcus [1]. In the medical field, the enzyme is primarily utilized as a critical diagnostic tool; it serves as the core component in biosensors and clinical assays designed to monitor phenylalanine levels in patients with Phenylketonuria (PKU) [3, 5]. Beyond its diagnostic utility, research has explored the potential of PheDH as an enzyme substitution therapy to lower toxic systemic phenylalanine levels, similar to the application of phenylalanine ammonia-lyase [4]. Additionally, PheDH is employed in industrial biocatalysis for the stereospecific synthesis of L-phenylalanine and other chiral amino acids [6]. Its high specificity for L-phenylalanine makes it an essential molecule for both metabolic monitoring and biotechnological production.

Other names
L-phenylalanine dehydrogenasePhenylalanine:NAD+ oxidoreductase (deaminating)PheD
02

Mechanism of action

Catalyzes the reversible NAD+-dependent oxidative deamination of L-phenylalanine to phenylpyruvate, ammonia, and NADH [1, 2].

03

Biological functions

Amino acid metabolismOxidative deaminationNitrogen metabolismPhenylalanine catabolism
04

Disease associations

Phenylketonuria (PKU)Hyperphenylalaninemia
05

Safety considerations

Immunogenicity of non-human proteins in therapeutic applicationsDiagnostic cross-reactivity with other branched-chain amino acids
06

Interacting drugs

L-Phenylalanine

3 more in the full profile.

07

Biomarkers

Blood phenylalanine levels

Beyond the preview

Go deeper on Phenylalanine dehydrogenase (PheDH).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phenylalanine dehydrogenase (PheDH).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call